Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial



Status:Completed
Conditions:Breast Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:21 - 75
Updated:10/5/2018
Start Date:March 2008
End Date:October 2018

Use our guide to learn which trials are right for you!

The Use of Alloderm in Two-Stage, Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial

Following mastectomy (removal of your breast), reconstruction of your breast(s) can be
performed using tissue expanders and implants. At the same operation as your mastectomy, a
tissue expander is put under the skin and muscles of your chest.

Following your surgery, the tissue expander is gradually filled with salt water over a period
of months. Once the expander is filled to the size of your new breast, a second operation is
performed. At this time, the tissue expander is removed and a permanent breast implant is
placed. This is a standard procedure. We are interested in learning about the use of AlloDerm
in breast reconstruction. AlloDerm can be used instead of some of your own chest muscles, in
order to cover and protect a tissue expander. We want to know if the use of AlloDerm can
decrease your pain or discomfort after surgery and after the filling of your tissue expander.

AlloDerm is made from human tissue. When AlloDerm is made all the cells that could cause your
body to reject it are removed. When it is placed in your chest, your own cells will then grow
into the AlloDerm, causing it to act like the muscle it is replacing. In this study, you will
either have reconstruction with AlloDerm or without AlloDerm.


Inclusion Criteria:

- Patients who undergo immediate, postmastectomy, tissue expander/implant reconstruction

- Patients ≥ 21 and ≤ 75 years of age

Exclusion Criteria:

- Patient refusal

- Patients who will undergo any of the following:

- Single-stage implant reconstruction

- Combined autogenous tissue expander/implant reconstruction

- Patients with a history of prior irradiation

- Patients with a history of prior surgery with breast implants

- Patients with a history of prior axillary lymph node dissection

- Patients who are pregnant

The following eligibility will be confirmed at the time of surgery.

- Patients who are deemed intraoperatively by the attending surgeon to have significant
mastectomy flap ischemia.

- Patients who have an axillary lymph node dissection at the time of mastectomy
(Patients undergoing sentinel lymph biopsy are eligible)
We found this trial at
3
sites
1500 E Medical Center Dr
Ann Arbor, Michigan 48109
(734) 936-4000
University of Michigan Health System The University of Michigan is home to one of the...
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
333 South Columbia Street
Chapel Hill, North Carolina 27599
?
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
1275 York Ave
New York, New York 10021
(212) 639-2000
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials